FOXP3isaforkheadtranscriptionfactorfamilymemberinvolvedinT-cellregulation,activationanddifferentiation.FOXP3hasbeenshowntobeamastercontrolgeneforthedevelopmentandfunctionofCD4+/CD25+regulatoryT-cells.InIHC,FOXP3hasbeenshowntobeaspecificMarkerforadultT-cellleukemia/lymphoma(1).Inmelanomaandinbreastandlungcancers,highnumbersofcirculatingregulatoryTcellshavebeenassociatedwithdiseaseprogression(2-5).Conversely,theinfiltrationofFOXP3+regulatoryTcellsintoinvasivetumorshasalsobeenreportedtobeassociatedwithsurvivalinavarietyofcancers(2-7).Incoloncancers,ahighfrequencyofFOXP3+infiltrateshasshowntobeapositiveindicator(6-7).PatientswithhighFOXP3expressioninCrohn’sdiseasehaveshownabetterresponsetoinfliximabtherapy(8).Inallographyrecipients,FOXP3celllevelsmayalsobeusefulinimprovingpost-transplantmanagement(9).
ByLetter | F |
---|---|
IntendedUse | IVD |
Format | Concentrate,Predilute |
Clone | 86D |
Volume | 0.1ml,1.0ml,6.0ml |
Isotype | IgG1 |
Localization | Nucelar |
PositiveControl | Coloncancerandtonsil |
1.RoncadorG,etal.FOXP3,aselectivemarkerforasubsetofadultT-cellleukaemia/lymphoma.Leukemia.2005Dec;19(12):2247-53.
2.GerberAL,etal.HighexpressionofFOXP3inprimarymelanomaisassociatedwithtumorprogression.BrJDermatol.2014Jan;170(1):103-9.
3.AliHR,etal.AssociationbetweenCD8+T-cellinfiltrationandbreastcancersurvivalin12,439patients.AnnOncol.2014Aug;25(8):1536-43.
4.LiuH,etal.Tumor-infiltratinglymphocytespredictresponsetochemotherapyinpatientswithadvancenon-smallcelllungcancer.CancerImmunolImmunother.2012Oct;61(10):1849-56.
5.TaoH,etal.Densityoftumor-infiltratingFOXP3+TcellsasaresponsemarkerforinductionchemorADIotherapyandapotentialprognosticfactorinpatientstreatedwithtrimodalitytherapyforlocallyadvancednon-smallcelllungcancer.AnnThoracCardiovascSurg.2014;20(6):980-6.
6.LingA,etal.TheintratumouralsubsiteandrelationofCD8(+)andFOXP3(+)Tlymphocytesincolorectalcancerprovideimportantprognosticclues.BrJCancer.2014May13;110(10):2551-9.
7.FreyDM,etal.Highfrequencyoftumor-infiltratingFOXP3(+)regulatoryTcellspredictsimprovedsurvivalinmismatchrepairproficientcolorectalcancerpatients.IntJCancer.2010Jun1;126(11):2635-43.
8.SloanS,etal.FOXP3+regulatoryT-cellcountscorrelatewithhistologicalresponseinCrohn’scolitistreatedwithinfliximab.PatholInt.2014Dec;64(12):624-7.
9.StenardF,etal.DecreasesincirculatingCD4+CD25hiFOXP3+cellsandincreasesinintragraftFOXP3+cellsaccompanyallograftrejectioninpediatricliverallograftrecipients.PediatrTransplant.2009Feb;13(1):70-80.
10.CenterforDiseaseControlManual.Guide:SafetyManagement,NO.CDC-22,Atlanta,GA.April30,1976“DecontaminationofLaboratorySinkDrainstoRemoveAzideSalts.”
11.ClinicalandLaboratoryStandardsInstitute(CLSI).ProtectionofLaboratoryWorkersfromOccupationallyAcquiredInfections;ApprovedGuideline-FourthEditionCLSIdocumentM29-A4Wayne,PA2014.
Biocare医学教育外展计划通过Biocare仪器和试剂的技术教育为我们目前和潜在的客户提供支持。教育外展团队致力于通过教育指导,材料和计划使每个客户成功。我们将最新的科学发现纳入我们的培训中,提供新鲜,相关的内容。我们的目标是让受训人员以信心和专业知识来培训其同事,以掌握返回实验室所需的主题知识。
Biocare医学教育推广计划提供全面的培训,在我们的教育中心和培训实验室中使科学理论与实际实践学习保持平衡。小班授课和个性化的教学模块允许在高素质的技术专家的带领下定制课程。
在加利福尼亚州康科德市的生物保健医学教育中心和培训实验室接受培训
网络研讨会
大事记
Biocare Medical是国家组织技术培训协会的骄傲,提供NSH认可的课程。